Strickland D.Disease State Management Sourcebook 1998. New York: Faulkner & Gray; 1997:279-283.
2.
2.“HMO Development of Disease Management.”HMO Industry Report, The InterStudy Competitive Edge Series. Cited in “Disease Management Programs Survey.” Managed Healthcare News1998(Jun); 14 (6):5.
3.
Summers Kh..“Measuring and Monitoring Outcomes of Disease Management Programs.”.Clin Ther. 1996;18:1341-1348
4.
Hadsall Rs,Sargent Lf..“Disease State Management.”.J Man Care Pharm. 1995;1:127-132
5.
Woodward Bw..“Disease Management: Opportunity for Pharmaceutical Care?”.Hosp Pharm. 1995;30:596-608
6.
Gonzalez E,Crane Vs..“Designing a Disease Management Program: How to Get Started.”.Formulary. 1995;30:326 331 337 340-328 333 338
7.
Tindall W..“Marketing to Managed Care Pharmacy: Think Local, Think Partnerships, Think Outcomes, Think Disease State Management.”.J Phar Mar & Man. 1996;10:177-193
8.
Drugalis Jr,Coons Sj..“Introduction: Disease Management—Separating Fact from Fantasy.”.Clin Ther. 1996;18:1318-1320
9.
Lina Ha..“Disease Management in the Alternate-Site Health Care Setting.”.Am J Health-Syst Pharm. 1998;55:471-476
10.
Monaghan Mj,Monaghan Ms.Managing the Patient with Type 2 Diabetes. Wilson Al, ed. Gaithersburg, MD: Aspen Publishers, Inc.; 1997:129-133.
11.
Munroe Wp..“Clinical Monitoring Plans for the Delivery of Pharmaceutical Care.”.J Am Pharm Assoc. 1996;NS36:397-402
12.
Position Paper on Disease State Management.. Alexandria, VA: Academy of Managed Care Pharmacy; 1998:
13.
Terry K..“Where Disease Management is Paying Off.”.Med Econ. 1997;74 (14): 62-69
14.
Hughes T..“Research in Managed Care: Outcomes Research in Disease Prevention and Management.”.J Man Care Pharm. 1996;2:212-222
15.
Plocher Dw.The Managed Health Care Handbook. Kongstvedt Pr, ed. Gaithersburg, MD: Aspen Publishers, Inc.; 1996:318-329.
16.
Simon Wa,Howard Ar..“Can Type 2 Diabetes Be Prevented?”.US Pharm. 1998;HS7:11-17
17.
Disease State Management Sourcebook 1998. New York: Faulkner & Gray; 1997:284-285.
